Search

Your search keyword '"Gonzalez-Lama, Yago"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Gonzalez-Lama, Yago" Remove constraint Author: "Gonzalez-Lama, Yago"
96 results on '"Gonzalez-Lama, Yago"'

Search Results

1. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease

2. Documento de posicionamiento. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre sexualidad y enfermedad inflamatoria intestinal

5. Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group

6. Comparison of original and biosimilar infliximab (CTP-13) in biologic-naive patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain

9. Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis

10. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento de pacientes con enfermedad inflamatoria intestinal asociada a espondiloartritis

11. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group

16. Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases

17. Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience

20. Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response

23. Corrigendum to: Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study

27. Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: A multicentre study

28. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group

33. Tu1926 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study

34. Su1329 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study

36. Mo1343 Inflammatory Bowel Disease Unclassified in Real Practice: Prevalence, Clinical Course and Therapy Requirements

38. W1313 Adalimumab for Luminal and Perianal Crohn's Disease in Real Practice: A Long-Term Multicenter Study of Effectiveness, Safety and Predictors of Response

39. W1273 Thiopurine-Induced Myelotoxicity in Inflammatory Bowel Disease (IBD): A Multicenter Study

40. W1262 Genetic Mutations of Thiopurine-Methyltransferase (TPMT) in Inflammatory Bowel Disease Patients With Normal TPMT Phenotype and Thiopurine-Induced Myelotoxicity

46. S1185 Faecal Calprotectin's Utility in the Prediction of Inflammatory Bowel Disease (IBD) Relapses

50. Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study

Catalog

Books, media, physical & digital resources